Similarly, monoclonal antibody proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9is), which are sometimes prescribed in pediatric FH or adults, have only modest or inconsistent effects on Lp(a) [65,66,67,68]. The gene discussed is LPA; the disease is familial hyperaldosteronism.